News

Important Safety Information on the Importation of US-Authorized Vasopressin Injection, USP, 20 units/mL (for intravenous infusion)

Importation of Fresenius Kabi's US-labelled Naropin® (Ropivacaine Hydrochloride) Injection 2 mg/mL, USP (200 mg per 100 mL and 400 mg per 200 mL)

Importation of Fresenius Kabi’s US-authorized Acyclovir Injection, USP 500 mg per 10 mL

Important Notice: McKesson Distribution Partners (MDP) Transitioning to SAP S/4HANA and Integrating Operations with McKesson Specialized Distribution (MSD)

Fighting Against Forced Labour and Child Labour in Supply Chains Act, S.C. 2023, c. 9 Annual Report

Fresenius Kabi Canada has received a Health Canada Notice of Compliance (NOC) for Otulfi™* an Ustekinumab Biosimilar